How big is the U.S. cancer biopsy market?

The U.S. cancer biopsy market size was estimated at USD 10.21 billion in 2023 and is expected to be worth around USD 29.34 billion by 2033

What is the U.S. cancer biopsy market growth?

The U.S. cancer biopsy market is expected to grow at a compound annual growth rate of 11.13% from 2023 to 2033

Who are the key players in the U.S. cancer biopsy market?

Some key players operating in the U.S. cancer biopsy market include BD (Becton, Dickinson And Company), IZI Medical Products, Johnson & Johnson Services, Inc., Argon Medical, Spectra Medical Devices, Inc., Medtronic, Boston Scientific Corporation, CONMED Corporation, INRAD, Inc., and Thermo Fisher Scientific, Inc.

U.S. Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Fine-needle Aspiration, Core, Surgical, Skin Biopsy/Punch Biopsy), By Application, By Site, And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

Report Details

Report Code:6586
Category:Healthcare
No. of Pages:150+
Format:PDF/PPT/Excel
Published:April 2025
Historical Year:2021-2023
Base Year:2024
Estimated Year:2025-2034

Get a Sample

Proceed To Buy

Deep Dive Analysis

USD 3800

Databook

USD 1900

Competitive Intelligence

USD 1200

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others

Ask To Expert